Biocon Shares Rise After Mylan Exits Following Rs. 3,676-Crore Stake Sale

Biocon shares jump 6% on reports of ₹3,481-crore block deal; Mylan likely to exit after 17 years

Mylan to sell up to $363 million stake in India’s Biocon, term sheet shows

SINGAPORE, July 13 (Reuters) - Mylan Inc plans to sell up to 92 million shares in Indian drugmaker Biocon Ltd, worth up to 34.81 billion Ind

Biocon block deal today: Mylan may sell Rs 3,481 crore worth of shares in pharma major

According to Business Today sources, the floor price has been set at Rs 378.50 per share, a 7.9 per cent discount to Biocon's Monday closing

Biocon share price climbs 5% after block deals on NSE, BSE; key details

Biocon stock rose 4.96 per cent to Rs 430.95 apiece after sources had earlier indicated that the floor price for the block deal was set at R

Biocon to see block deals, as Viatris plans to exit

Floor price has been fixed as ₹378.50 a share, a discount of 7.9 per cent to current price

Biocon stock ticks up as Yesafili Biosimilar clinical data gets published in peer-reviewed journals

CEO Shreehas Tambe called the publications an important milestone for the company’s aflibercept biosimilar programme